Skip Navigation



Carcinogenesis Advance Access published online on September 16, 2004

Carcinogenesis, doi:10.1093/carcin/bgh282
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
26/1/145    most recent
bgh282v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Zhu, W.
Right arrow Articles by Sauter, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, W.
Right arrow Articles by Sauter, E. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received June 26, 2004
Revised August 9, 2004
Accepted September 5, 2004

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid1

Weizhu Zhu 1, Wenyi Qin 1, Paul Bradley 1, Amy Wessel 1, Charles L. Puckett 1, and Edward R. Sauter 1*

1 Ellis Fischel Cancer Center and Department of Surgery, University of Missouri, Columbia, MO 65212

* To whom correspondence should be addressed. E-mail: sautere{at}health.missouri.edu.


   Abstract

Background: Unlike nuclear (n)DNA, of which there is one paired copy per cell, there are many copies of mitochondrial (mt)DNA per cell, making PCR amplification of mtDNA easier in samples of limited cellularity. The aims of this study were to 1) determine the mutation patterns of breast cancers through a comprehensive screen of mtDNA mutations, and 2) assess if mutations in the cancers are also detectable in breast nipple aspirate fluid (NAF), a physiologic fluid which contains shed ductal epithelial cells. Materials and methods: 15 breast cancers, matched benign tissues and NAF were collected. 9 overlapping primer sets were used to sequence the entire mitochondrial genome from tissue samples. For NAF samples, we focused on the 19 np where mutations were found in a 3701bp region (np15331 to 2463) which includes the D-loop, a mtDNA mutation hot spot. Results: 14/15 (93%) cancer samples had ≥1 somatic mtDNA mutation for a total of 45 at 35 nucleotide positions (9 np previously reported, 26 new). 9/15 tumors had ≥2 mutations. The D-loop contained 17/45 (38%) and non D-loop (coding) regions contained 28 (62%) mutations. Of the 28 mutations in coding loci, 11 led to an amino acid change. The frequency of mtDNA mutations was higher in the D-loop region (1.5% vs 0.18% of loci). 155 polymorphisms were identified (98 previously reported, 57 new). 16/45 (36%) mutations were located at polymorphism sites. 4/19 mtDNA mutations in 10 cancers located between np15331 and 2463 were found in matched NAF (2/11 mutations in the D-loop and 2/8 in non D-loop regions). No mutations were found in 5 matched NAF samples from women whose cancers lacked a mutation in the same region. Conclusion: mtDNA mutations in breast cancer occur both within and outside of the D-loop, though the mutation rate in the D-loop is over 7 fold higher than in coding areas. We identified 26 new mutation loci (25 in regions sequenced by others, one in an area not). The high frequency of mtDNA mutations at polymorphic loci requires further investigation. mtDNA mutations in NAF may prove useful to aid in early breast cancer detection. Specific mtDNA mutations can be detected in a subset of NAF samples from women with breast cancer.

Keywords: mitochondrial DNA; mutation; breast cancer; nipple aspirate fluid; direct DNA sequencing; PCR.

1 Supported in part by Department of Defense grant DAMD17-01-1-0426


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Ye, Y.-T. Gao, W. Wen, J. P. Breyer, X. O. Shu, J. R. Smith, W. Zheng, and Q. Cai
Association of Mitochondrial DNA Displacement Loop (CA)n Dinucleotide Repeat Polymorphism with Breast Cancer Risk and Survival among Chinese Women
Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2117 - 2122.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
F. Mannello and G. A.M. Tonti
Benign Breast Diseases: Classification, Diagnosis, and Management
Oncologist, November 1, 2006; 11(10): 1132 - 1134.
[Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
R. L. Parr, G. D. Dakubo, K. A. Crandall, J. Maki, B. Reguly, A. Aguirre, R. Wittock, K. Robinson, J. S. Alexander, M. A. Birch-Machin, et al.
Somatic Mitochondrial DNA Mutations in Prostate Cancer and Normal Appearing Adjacent Glands in Comparison to Age-Matched Prostate Samples without Malignant Histology
J. Mol. Diagn., July 1, 2006; 8(3): 312 - 319.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. R. Sartippour, L. Zhang, M. Lu, H.-J. Wang, and M. N. Brooks
Nipple Fluid Basic Fibroblast Growth Factor in Patients with Breast Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2995 - 2998.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.